Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Libon F, Arrese JE, Rorive A, Nikkels AF
Bottom Line Here's what the data tells us: GI side effects dominate: nausea, diarrhea, vomiting, constipation Higher efficacy = slightly higher side effects at maximum doses Glucagon adds benefits: liver fat reduction, increased energy expenditure Slow escalation helps: 20+ week titration minimizes symptoms Still investigational: Phase 3 trials ongoing, FDA decision expected 2025-2026 Sources Retatrutide Phase 2 Trial (Jastreboff et al., NEJM 2023) TRIUMPH Phase 3 Trial (ClinicalTrials.gov) ClinicalTrials.gov Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice
Food & Drug Administration (2021) FDA approves first generic of once-daily GLP-1 injection to lower blood sugar in patients with type 2 diabetes, U.S
Its a prescription drug thats used in adults with type 2 diabetes
US$ 20.88
US$ 22.34
US$ 23.72
US$ 26.16
US$ 20.62
US$ 28.66
US$ 28.63
